These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3266358)

  • 1. Presence of interferon and anti-interferon in patients with systemic lupus erythematosus.
    von Wussow P; Jakschies D; Hartung K; Deicher H
    Rheumatol Int; 1988; 8(5):225-30. PubMed ID: 3266358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus.
    von Wussow P; Jakschies D; Hochkeppel H; Horisberger M; Hartung K; Deicher H
    Arthritis Rheum; 1989 Jul; 32(7):914-8. PubMed ID: 2751723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia.
    Slavikova M; Schmeisser H; Kontsekova E; Mateicka F; Borecky L; Kontsek P
    J Interferon Cytokine Res; 2003 Mar; 23(3):143-7. PubMed ID: 12716486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus.
    Sibbitt WL; Gibbs DL; Kenny C; Bankhurst AD; Searles RP; Ley KD
    Arthritis Rheum; 1985 Jun; 28(6):624-9. PubMed ID: 2408630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine.
    Harris BD; Kuruganti S; Deshpande A; Goepfert PA; Chatham WW; Walter MR
    Lupus; 2020 Aug; 29(9):1095-1105. PubMed ID: 32611267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Circulating interferon in patients with systemic lupus erythematosus. A prospective study].
    Dudli C; Kaiser V; Aguet M; Joller H; Pichler WI; Grob PJ; Fontana A
    Schweiz Med Wochenschr; 1986 Jan; 116(4):104-9. PubMed ID: 2419975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of anti-interferon antibodies in systemic lupus erythematosus.
    Suit BE; Axelrod D; Moutsopoulos HM; Decker JL; Hooks JJ
    Clin Exp Rheumatol; 1983; 1(2):133-5. PubMed ID: 6442634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interferon levels in patients with systemic lupus erythematosus.
    Ytterberg SR; Schnitzer TJ
    Arthritis Rheum; 1982 Apr; 25(4):401-6. PubMed ID: 6176248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum activity that confers acid lability to alpha-interferon in systemic lupus erythematosus: its association with disease activity and its independence from circulating alpha-interferon.
    Yee AM; Yip YK; Fischer HD; Buyon JP
    Arthritis Rheum; 1990 Apr; 33(4):563-8. PubMed ID: 2328034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.
    Lood C; Tydén H; Gullstrand B; Klint C; Wenglén C; Nielsen CT; Heegaard NH; Jönsen A; Kahn R; Bengtsson AA
    PLoS One; 2015; 10(4):e0125109. PubMed ID: 25897671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
    Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative study of anti-double stranded DNA antibody levels measured by radioimmunoassay and enzyme-linked immunosorbent assay in systemic lupus erythematosus.
    Takeuchi Y; Ishikawa O; Miyachi Y
    J Dermatol; 1997 May; 24(5):297-300. PubMed ID: 9198317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
    Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
    Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon alpha associated with systemic lupus erythematosus is not intrinsically acid labile.
    Yee AM; Buyon JP; Yip YK
    J Exp Med; 1989 Mar; 169(3):987-93. PubMed ID: 2926326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus.
    Cruz J; Aviña-Zubieta A; Martínez de la Escalera G; Clapp C; Lavalle C
    Arthritis Rheum; 2001 Jun; 44(6):1331-5. PubMed ID: 11407692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum alpha interferon and lymphocyte inclusions in systemic lupus erythematosus.
    Klippel JH; Carette S; Preble OT; Friedman RM; Grimley PM
    Ann Rheum Dis; 1985 Feb; 44(2):104-8. PubMed ID: 2983625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus.
    Rose T; Grützkau A; Hirseland H; Huscher D; Dähnrich C; Dzionek A; Ozimkowski T; Schlumberger W; Enghard P; Radbruch A; Riemekasten G; Burmester GR; Hiepe F; Biesen R
    Ann Rheum Dis; 2013 Oct; 72(10):1639-45. PubMed ID: 23117242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
    Doe K; Nozawa K; Hiruma K; Yamada Y; Matsuki Y; Nakano S; Ogasawara M; Nakano H; Ikeda T; Ikegami T; Fujishiro M; Kawasaki M; Ikeda K; Amano H; Morimoto S; Ogawa H; Takamori K; Sekigawa I; Takasaki Y
    Lupus; 2014 Sep; 23(10):1031-41. PubMed ID: 24836587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum alpha-interferon and alpha-interferon antibody in children with allergic bronchial asthma and systemic lupus erythematosus].
    Liu WJ; Lu CC; Chiang CH; Huang TY; Liu HW
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1988; 29(3):159-66. PubMed ID: 3272988
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies.
    Bengtsson AA; Sturfelt G; Truedsson L; Blomberg J; Alm G; Vallin H; Rönnblom L
    Lupus; 2000; 9(9):664-71. PubMed ID: 11199920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.